The role of radiomics in prostate cancer radiotherapy
R Delgadillo, JC Ford, MC Abramowitz… - Strahlentherapie und …, 2020 - Springer
Abstract “Radiomics,” as it refers to the extraction and analysis of a large number of
advanced quantitative radiological features from medical images using high-throughput …
advanced quantitative radiological features from medical images using high-throughput …
The promise and future of radiomics for personalized radiotherapy dosing and adaptation
Quantitative image analysis, also known as radiomics, aims to analyze large-scale
quantitative features extracted from acquired medical images using hand-crafted or machine …
quantitative features extracted from acquired medical images using hand-crafted or machine …
CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK-Positive Non-small-cell Lung Cancer Treated With TKI Crizotinib: A Proof-of-Concept Study
Objectives: To identify a computed tomography (CT)-based radiomic signature for predicting
progression-free survival (PFS) in stage IV anaplastic lymphoma kinase (ALK)-positive non …
progression-free survival (PFS) in stage IV anaplastic lymphoma kinase (ALK)-positive non …
Generative adversarial networks can create high quality artificial prostate cancer magnetic resonance images
IRL Xu, DJ Van Booven, S Goberdhan, A Breto… - Journal of personalized …, 2023 - mdpi.com
The recent integration of open-source data with machine learning models, especially in the
medical field, has opened new doors to studying disease progression and/or regression …
medical field, has opened new doors to studying disease progression and/or regression …
Phase I trial of MRI-guided prostate cancer lattice extreme ablative dose (LEAD) boost radiation therapy
Purpose A phase I clinical trial was designed to test the feasibility and toxicity of
administering high-dose spatially fractionated radiation therapy to magnetic resonance …
administering high-dose spatially fractionated radiation therapy to magnetic resonance …
Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with …
M Gibbons, JP Simko, PR Carroll… - Magnetic Resonance …, 2023 - Elsevier
Multi-parametric MRI (mpMRI) has proven itself a clinically useful tool to assess prostate
cancer (PCa). Our objective was to generate PCa risk maps to quantify the volume and …
cancer (PCa). Our objective was to generate PCa risk maps to quantify the volume and …
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI
Simple Summary In this study, we built clinical-and radiomics-based models to predict
lesions/patients at low risk based on a combined clinical-genomic classification system …
lesions/patients at low risk based on a combined clinical-genomic classification system …
Visualising spatial heterogeneity in glioblastoma using imaging habitats
M Waqar, PJ Van Houdt, E Hessen, KL Li, X Zhu… - Frontiers in …, 2022 - frontiersin.org
Glioblastoma is a high-grade aggressive neoplasm characterised by significant intra-tumoral
spatial heterogeneity. Personalising therapy for this tumour requires non-invasive tools to …
spatial heterogeneity. Personalising therapy for this tumour requires non-invasive tools to …
Multi‐parametric MRI (mpMRI) for treatment response assessment of radiation therapy
Magnetic resonance imaging (MRI) plays an important role in the modern radiation therapy
(RT) workflow. In comparison with computed tomography (CT) imaging, which is the …
(RT) workflow. In comparison with computed tomography (CT) imaging, which is the …
Habitats in DCE-MRI to predict clinically significant prostate cancers
NA Parra, H Lu, J Choi, K Gage, J Pow-Sang, RJ Gillies… - Tomography, 2019 - mdpi.com
Prostate cancer identification and assessment of clinical significance continues to be a
challenge. Routine multiparametric magnetic resonance imaging has shown to be useful in …
challenge. Routine multiparametric magnetic resonance imaging has shown to be useful in …